how to get semaglutide approved by insurance coverage just changed for as many as 56 million Americans when it comes the popular GLP-1 medications used to promote weight loss. Read more: https://thehill.com/policy/healthcare/5972729-glp-1-insurance-change-impacts-millions-of I've been on semaglutide for

Description

Outcomes form the STEER real-world study have revealed that semaglutide 2.4 mg had 57% greater risk reduction for heart attack, stroke and cardiovascular-related death or death from any cause, in people with overweight or obesity and CVD, who did not have any gaps in their treatment lasting more than 30 days, compared with tirzepatide

Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.

Development of a ligand-based proximity labeling strategy enables interrogation of the native cell membrane interactome for the GLP-1 receptor in two cell types, revealing new regulators of receptor-mediated signaling and cell responses.